| Autor: |
Schwimmbeck PL; Department of Internal Medicine/Cardiology, Benjamin Franklin Hospital, Charite-Medical School Berlin, Free University of Berlin, Hindenburgdamm 30, 12200 Berlin, Germany. peter.schwimmbeck@charite.de, Bigalke B, Schulze K, Pauschinger M, Kühl U, Schultheiss HP |
| Jazyk: |
angličtina |
| Zdroj: |
Medical microbiology and immunology [Med Microbiol Immunol] 2004 May; Vol. 193 (2-3), pp. 115-9. Date of Electronic Publication: 2004 Feb 04. |
| DOI: |
10.1007/s00430-003-0217-7 |
| Abstrakt: |
Several lines of evidence suggest a viral infection as the initiating event for the development of myocarditis (MC). Especially enteroviruses like coxsackie B3 virus have been shown to induce MC in humans and strains of MC-prone mice after an infection. The further course of the disease is, however, determined not only by the viral infection but also by the host's immune system. Both the humoral and the cellular immune system can modify the extent of the damage caused by the disease. The humoral immune system mounts an anti-viral immune response immediately after the infection; however, during the course of the disease, autoantibodies against a variety of different autoantigens emerge. The epitopes recognized by the anti-viral antibodies and those of several autoantibodies have been identified using synthetic peptides. The human disease could be transferred into SCID mice using peripheral blood leukocytes of patients, suggesting a pathophysiological significance of the autoimmune reaction. However, the significance of the humoral immune responses needs to be tested in randomized, prospective studies using immunoadsorption of autoantibodies in patients with inflammatory cardiomyopathy. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink